Antidepressants for depression in stage 3–5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP)*

The pharmacokinetics and safety of desvenlafaxine in subjects with chronic renal impairment

(2011) A.I. Nichols et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Epidemiology, Diagnosis, and Management of Depression in Patients With CKD

(2009) S. Susan Hedayati et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Antidepressants and Falls in the Elderly

(2009) Adam Darowski et al.   DRUGS & AGING

Sertraline treatment is associated with an improvement in depression and health-related quality of life in chronic peritoneal dialysis patients

(2009) Huseyin Atalay et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

No Influence of Dialysis on Mirtazapine – A Case Report

(2008) P. Schlotterbeck et al.   PHARMACOPSYCHIATRY

Depression in Patients With Chronic Renal Disease: Where Are We Going?

(2007) Paul L. Kimmel et al.   JOURNAL OF RENAL NUTRITION

PSYCHOSOCIAL FACTORS IN PATIENTS WITH CHRONIC KIDNEY DISEASE: The Identification and Treatment of Depression in Patients Maintained on Dialysis

(2005) Diane Wuerth et al.   SEMINARS IN DIALYSIS